Earnings summaries and quarterly performance for Pharma-Bio Serv.
Executive leadership at Pharma-Bio Serv.
Board of directors at Pharma-Bio Serv.
Research analysts covering Pharma-Bio Serv.
Recent press releases and 8-K filings for PBSV.
Pharma-Bio Serv Announces Full Year 2025 Results and Special Dividend
PBSV
Earnings
Dividends
Demand Weakening
- Pharma-Bio Serv reported revenues of approximately $9.0 million for the year ended October 31, 2025, representing a decrease of approximately $0.5 million compared to the previous year.
- The company also reported a net loss of approximately $0.1 million for the year ended October 31, 2025, which was an improvement of approximately $0.7 million compared to the prior year.
- The Board of Directors approved a Special Dividend of $0.075 per share, payable on or about March 20, 2026, to shareholders of record at the close of business on February 27, 2026.
Jan 29, 2026, 10:07 PM
Pharma-Bio Serv Announces Q3 2025 Financial Results
PBSV
Earnings
Demand Weakening
New Projects/Investments
- Pharma-Bio Serv, Inc. reported revenues of approximately $2.0 million for the three months ended July 31, 2025, and $6.9 million for the nine months ended July 31, 2025. These figures are a decrease from $2.4 million and $7.2 million, respectively, in the same periods last year.
- The company posted a net loss of approximately $0.2 million for the three months ended July 31, 2025, and a net loss of approximately $0.1 million for the nine months ended July 31, 2025. This represents an earnings increase of $0.1 million and $0.7 million, respectively, compared to the prior year periods.
- CEO Mr. Sanchez stated that the company has streamlined its cost structure, prioritized core business segments, and is preparing for the immediate commencement of several significant projects.
Sep 15, 2025, 9:27 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more